{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T04:46:21Z","timestamp":1777610781195,"version":"3.51.4"},"reference-count":26,"publisher":"Japan Endocrine Society","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Endocr J"],"published-print":{"date-parts":[[2011]]},"DOI":"10.1507\/endocrj.ej11-0039","type":"journal-article","created":{"date-parts":[[2011,9,5]],"date-time":"2011-09-05T05:20:32Z","timestamp":1315200032000},"page":"969-977","source":"Crossref","is-referenced-by-count":10,"title":["Transient changes in thyroid functions tests after zoledronic acid infusion"],"prefix":"10.1507","volume":"58","author":[{"given":"Helen","family":"Karga","sequence":"first","affiliation":[{"name":"Second Division of Endocrinology, Alexandra Hospital, Athens, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irene","family":"Giagourta","sequence":"additional","affiliation":[{"name":"Second Division of Endocrinology, Alexandra Hospital, Athens, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Garyphallia","family":"Papaioannou","sequence":"additional","affiliation":[{"name":"Second Division of Endocrinology, Alexandra Hospital, Athens, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paraskevi","family":"Katsichti","sequence":"additional","affiliation":[{"name":"Second Division of Endocrinology, Alexandra Hospital, Athens, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Argyris","family":"Pardalakis","sequence":"additional","affiliation":[{"name":"Second Division of Endocrinology, Alexandra Hospital, Athens, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Georgia","family":"Kassi","sequence":"additional","affiliation":[{"name":"Second Division of Endocrinology, Alexandra Hospital, Athens, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Apostolia","family":"Zagoreou","sequence":"additional","affiliation":[{"name":"Second Division of Endocrinology, Alexandra Hospital, Athens, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Triantaphyllopoulou","sequence":"additional","affiliation":[{"name":"Second Division of Endocrinology, Alexandra Hospital, Athens, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cherry","family":"Zerva","sequence":"additional","affiliation":[{"name":"Second Division of Endocrinology, Alexandra Hospital, Athens, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"386","reference":[{"key":"1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa067312"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Reid IR, Miller P, Lyles K, Frasen W, Brown JP, Saidi Y, Mesenbrink P, Su G, Pak J, Zelenakas K, Luchi M, Richardson P, Hosking D (2005) Comparson of a single infusion of zoledronic acid with risedronate for Paget’s disease. N Engl J Med <\/i>353: 898-908.","DOI":"10.1056\/NEJMoa044241"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Coleman R, Cook R, Hirsh V, Major P, Lipton A (2011) Zoledronic acid use in cancer patients: more than just supportive care? Cancer<\/i> 117: 11-23.","DOI":"10.1002\/cncr.25529"},{"key":"4","doi-asserted-by":"publisher","DOI":"10.1007\/s002239900353"},{"key":"5","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2010-0597"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Dicuonzo G, Vincenzi B, Santini D, Santini D, Avvisati G, Rocci L, Battistoni F, Gavasci M, Borzomati D, Coppola R, Tonini G (2003) Fever after zolendronic acid administration is due to increase in TNF-alpha and IL-6. J Interferon<\/i> Cytokine Res<\/i> 23(11): 649-654.","DOI":"10.1089\/107999003322558782"},{"key":"7","doi-asserted-by":"publisher","DOI":"10.1210\/jc.84.1.151"},{"key":"8","unstructured":"8. Adler SM, Wartofsky L (2007) The nonthyroidal illness syndrome. Endocrinol Metab Clin N Am <\/i>36: 657-672."},{"key":"9","doi-asserted-by":"publisher","DOI":"10.1677\/JOE-09-0412"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Maia AL, Kim BW, Huang SA, Harney JW, Larsen PR (2005) Type 2 iodothyronine deiodinase is the major source of plasma T3 in euthyroid humans. J Clin Invest<\/i> 115: 2524-2533.","DOI":"10.1172\/JCI25083"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Boelen A, Kwakkel J, Wieland CW, StGermain DL, Fliers E, Hernandez A (2009) Impaired bacterial clearance in type 3 deiodinase-deficient mice infected with streptococcus pneumoniae. Endocrinology<\/i> 150: 1984-1133.","DOI":"10.1210\/en.2008-1133"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Chen T, Berenson J, Vescio R, Swift R, Glichick A, Goodin S, LoRusso P, Ma P, Ravera C, Deckert F, Schran H, Seaman J, Skerjanec A (2002) Pharmacokinetics and pharmacodynamics of zoledronic acid in cancer patients with bone matastases. J Clin Pharmacol<\/i> 42: 1228-1236.","DOI":"10.1177\/009127002762491316"},{"key":"13","doi-asserted-by":"publisher","DOI":"10.1007\/s10787-999-0008-x"},{"issue":"11","key":"14","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1055\/s-2007-999221","volume":"12","year":"1980","ISSN":"https:\/\/id.crossref.org\/issn\/0018-5043","issn-type":"print"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Samuels MH, Pillots K, Asher D, Nelson JC (2003) Variable effects of nonsteroidal antiinflammatory agents on thyroid test results. J Clin Endocrinol Metab<\/i> 88: 5710-5716.","DOI":"10.1210\/jc.2002-021869"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Hewitt RE, Lissina A, Green A, Slay ES, Price DA, Sewell AK (2005) The bisphosphonate acute phase response: rapid and copius production of proinflammatory cytokines by peripheral blood γδT cells in response to aminobisphosphonates is inhibited by statins. Clin Exp Immunol<\/i> 139: 101-111.","DOI":"10.1111\/j.1365-2249.2005.02665.x"},{"key":"17","doi-asserted-by":"publisher","DOI":"10.1007\/BF02556671"},{"key":"18","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.1993.tb02401.x"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Sánchez E, Singru PS, Fekete C, Lechan RM (2008) Induction of type 2 iodothyronine deiodinase in the mediobasal hypothalamus by becterial lipopolysaccharide: role of corticosterone. Endocrinology<\/i> 149: 2484-2493.","DOI":"10.1210\/en.2007-1697"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Karga H, Papaioannou P, Venetsanou K, Papandroulaki F, Karaloizos L, Papaioannou G, Papapetrou P (2000) The role of cytokines and cortisol in the nonthyroidal illness syndrome following acute myocardial infarction. Eur J Endocrinol <\/i>142: 236-242.","DOI":"10.1530\/eje.0.1420236"},{"key":"21","unstructured":"21. Michalaki M, Vagenakis AG, Makri M, Kalfarentzos F, Kyriazopoulou V (2001) Dissociation of the early decline in serum T(3) concentration and serum IL-6 rise and TNF alpha in nonthyroidal illness syndrome by abdominal surgery. J Clin Endocrinol Metab<\/i> 86: 4198-4205."},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Boelen A, Kwakkel J, Thijssen-Timmer DC, Alkemade A, Fliers E, Wiersinga WM (2004) Simultaneous changes in central and peripheral components of the hypothalamus-pituitary-thyroid axis in lipopolysaccharide-induced acute illness in mice. J Endocrinol<\/i> 182: 315-323.","DOI":"10.1677\/joe.0.1820315"},{"key":"23","unstructured":"23. Stouthard JM, van der Poll T, Endert E, Bakker PJ, Veenhof CH, Sauerwein HP, Romijn JA (1994) Effects of acute and chronic interleukin-6 administration on thyroid hormone metabolism in humans. J Clin Endocrinol Metab<\/i> 79: 1342-1346."},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Boelen A, Kwakkel J, Platvoet-ter Schiphorst MP, Mentrup B, Baur A, Koehrle J, Wiersinga WM (2004) Interleukin-18, a proinflammatory cytokine, contributes to the pathogenesis of non-thyroidal illness mainly via the central part of the hypothalamus-pituitary-thyroid axis. Eur J Endocrinol<\/i> 151: 497-502.","DOI":"10.1530\/eje.0.1510497"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Schwartzentruber DJ, White DE, Zweig MH, Weintraub BD, Rosenberg SA (1991) Thyroid dysfunction associated with immunotherapy for patients with cancer. Cancer <\/i>68: 2384-2390.","DOI":"10.1002\/1097-0142(19911201)68:11<2384::AID-CNCR2820681109>3.0.CO;2-A"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Baudin E, Marcellin P, Pouteau M, Colas-Linhart N, Le Floch JP, Lemmonier C, Benhamou JP, Bok B (1993) Reversibility of thyroid dysfunction induced by recombinant alpha interferon in chronic hepatitis C. Clin Endocrinol (Oxf)<\/i> 39: 657-661.","DOI":"10.1111\/j.1365-2265.1993.tb02423.x"}],"container-title":["Endocrine Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.jstage.jst.go.jp\/article\/endocrj\/58\/11\/58_EJ11-0039\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,13]],"date-time":"2021-04-13T06:06:20Z","timestamp":1618293980000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jstage.jst.go.jp\/article\/endocrj\/58\/11\/58_EJ11-0039\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011]]},"references-count":26,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.1507\/endocrj.ej11-0039","relation":{},"ISSN":["0918-8959","1348-4540"],"issn-type":[{"value":"0918-8959","type":"print"},{"value":"1348-4540","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011]]}}}